Strep Group B NAA is a lab test that detects Group B Streptococcus (GBS) bacteria using a method called nucleic acid amplification. Instead of growing bacteria in a lab dish over several days, this test identifies the genetic material of GBS directly from a swab sample, delivering results much faster. It’s most commonly ordered during pregnancy to determine whether a mother carries GBS bacteria that could potentially pass to her baby during birth.
How the Test Works
Nucleic acid amplification (NAA) is a broad term for lab techniques that make millions of copies of a specific stretch of DNA or RNA. If GBS genetic material is present in your sample, even in tiny amounts, the test amplifies it until it’s detectable. Think of it like a photocopier for bacterial DNA: if even a trace of GBS is in the swab, the test multiplies that signal until it’s impossible to miss.
The traditional way to screen for GBS is a bacterial culture, where the sample is placed in a nutrient broth and left to grow for 18 to 72 hours. NAA testing shortcuts that wait. Some rapid versions, like point-of-care PCR systems used in labor and delivery units, can return a result in under an hour. These systems are designed to be run by non-laboratory staff directly on the ward, which makes them especially useful when results are needed quickly.
Why It’s Done During Pregnancy
GBS is a bacterium that naturally lives in the digestive and genital tracts of roughly 25% of healthy adults. It usually causes no symptoms and isn’t considered an infection in the carrier. The concern arises during childbirth: a baby passing through the birth canal can pick up GBS, and in rare cases, this leads to serious infections like pneumonia, sepsis, or meningitis in the newborn’s first week of life.
The American College of Obstetricians and Gynecologists recommends that all pregnant women be screened for GBS between 36 weeks and 37 weeks 6 days of gestation. That timing creates a five-week window during which results remain valid, covering births that happen up to at least 41 weeks. If you test positive, you’ll receive antibiotics through an IV during labor. This approach has been remarkably effective: early-onset GBS disease in newborns dropped by 80% after routine screening became standard, falling from 1.7 cases per 1,000 live births in 1993 to 0.2 per 1,000 in 2023.
How the Sample Is Collected
The most sensitive method uses two separate swabs. One swab collects a sample from the vaginal opening, and a second collects from the rectum. Using two sites increases the chance of detecting GBS if it’s present. A cervical swab or the use of a speculum is not recommended because both reduce the test’s accuracy. Many providers have patients collect the swabs themselves, which is straightforward and takes only a few seconds.
NAA vs. Traditional Culture
NAA testing is highly sensitive, catching over 96% of true GBS carriers when the sample is first placed in enrichment broth before being tested. Its specificity, the ability to correctly identify people who don’t carry GBS, ranges from about 88% to 96%. That means false positives are possible, where the test says GBS is present when it isn’t. Traditional culture remains the reference standard because it’s slightly more reliable for ruling out false results, but it’s far too slow to help when a woman arrives in labor without prior screening.
This speed difference is the main reason NAA testing exists alongside culture. If you had your prenatal screening done weeks before delivery, the lab likely used a standard culture. But if you show up in labor and your GBS status is unknown, perhaps because you transferred care, missed an appointment, or went into preterm labor, a rapid NAA test can provide an answer fast enough to guide whether you receive antibiotics before delivery.
What a Positive Result Means
A positive Strep Group B NAA result means GBS genetic material was detected in your sample. It does not mean you have an infection or that you’re sick. It means you’re colonized, the bacteria are living on your body, and there’s a chance of passing them to your baby during a vaginal delivery. The standard response is intrapartum antibiotic prophylaxis: antibiotics given through an IV once labor begins, ideally at least four hours before delivery, to reduce the bacterial load in the birth canal.
Women who had GBS in their urine at any point during the current pregnancy, or who previously had a baby affected by GBS disease, automatically receive antibiotics during labor without needing a screening test. For everyone else, the NAA or culture result at 36 to 37 weeks determines the plan.
What a Negative Result Means
A negative result means no GBS DNA was found in the sample, and antibiotics during labor are generally not needed based on GBS status alone. Keep in mind that GBS colonization can come and go. A negative result at 36 weeks reflects your status at that moment, which is why the screening window is timed close to your due date rather than earlier in pregnancy. If you deliver well past 41 weeks, your provider may factor in the age of your result when making decisions.